Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 7
Submit an article Journal homepage
37
Views
1
CrossRef citations to date
0
Altmetric
Commentary

T-cell abnormalities in patients with chronic lymphocytic leukemia

Tait Shanafelt Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Rochester, MN, USACorrespondence[email protected]
&
Neil Kay Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Rochester, MN, USA
Pages 1197-1198 | Accepted 08 Mar 2006, Published online: 01 Jul 2009

References

  • Cohnen G, Konig E, Augener W, Brittinger G, Douglas S D. Lymphocyte populations in chronic lymphocytic leukaemia. Lancet 1973; 1: 259–260
  • Mackus W J, Frakking F N, Grummels A, Gamadia L E, De Bree G J, Hamann D, et al. Expansion of CMV-specific CD8+ CD45RA+ CD27− T cells in B-cell chronic lymphocytic leukemia. Blood 2003; 102: 1057–1063
  • Kay N E, Han L, Bone N, Williams G. Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis. Br J Haematol 2001; 112: 760–767
  • Cantwell M, Hua T, Pappas J, Kipps T J. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia. Nat Med 1997; 3: 984–989
  • Gorgun G, Holderried T A, Zahrieh D, Neuberg D, Gribben J G. Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J Clin Invest 2005; 115: 1797–1805
  • Fluckiger A C, Rossi J F, Bussel A, Bryon P, Banchereau J, Defrance T. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 1992; 80: 3173–3181
  • Kitada S, Zapata J M, Andreeff M, Reed J C. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia. Br J Haematol 1999; 106: 995–1004
  • Granziero L, Ghia P, Circosta P, Gottardi D, Strola G, Geuna M, et al. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood 2001; 97: 2777–2783
  • Beyer M, Kochanek M, Darabi K, Popov A, Jensen M, Endl E, et al. Reduced frequencies and suppressive function of CD4+ CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 2005; 106: 2018–2025
  • Kiaii S, Choudhury A, Mozaffari F, et al. Signaling molecules and cytokine production in T cells of patients with B-cell chroniclymphocytic leukemia: long-term effects of fludarabine and alemtuzumab treatment. Leuk Lymphoma 2006; 47: 1229–1238
  • Wierda W G, Kipps T J, Keating M J. Novel immune-based treatment strategies for chronic lymphocytic leukemia. J Clin Oncol 2005; 23: 6325–6332

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.